deferoxamine has been researched along with 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernhardt, PV; Islam, M; Kalinowski, DS; Kumar, N; Liao, YT; Lovejoy, DB; Richardson, DR; Sharpe, PC; Yu, Y | 1 |
| Bernhardt, PV; Kalinowski, DS; Richardson, DR; Sharpe, PC | 2 |
| Bernhardt, PV; Islam, M; Kalinowski, DS; Lovejoy, DB; Richardson, DR; Richardson, V; Sharpe, PC | 1 |
| Bernhardt, PV; Jansson, PJ; Kalinowski, DS; Kovacevic, Z; Lovejoy, DB; Richardson, DR; Sharpe, PC; Siafakas, AR; Stefani, C; Yu, Y | 1 |
| Bernhardt, PV; Jansson, PJ; Kalinowski, DS; Lovejoy, DB; Punnia-Moorthy, G; Richardson, DR; Sharpe, PC; Stefani, C | 1 |
| Kalinowski, DS; Kovacevic, Z; Merlot, AM; Mrozek-Wilczkiewicz, A; Musiol, R; Pantarat, N; Polanski, J; Ratuszna, A; Richardson, DR; Serda, M; Szurko, A | 1 |
| Basha, MT; Bernhardt, PV; Jansson, PJ; Kalinowski, DS; Lovejoy, DB; Obeidy, P; Prichard, T; Richardson, DR; Seebacher, N; Sharp, DM; Sharpe, PC; Stefani, C | 1 |
| Bernhardt, PV; Gutierrez, E; Jansson, PJ; Kalinowski, DS; Richardson, DR; Stefani, C | 1 |
| Hašková, P; Hergeselová, T; Hrušková, K; Kovaříková, P; Liptáková, L; Mingas, P; Potůčková, E; Šimůnek, T; Vávrová, K | 1 |
| Darnell, G; Richardson, DR | 1 |
| Antholine, WE; Chitambar, CR; Green, DA; Richardson, DR; Wong, SJ | 1 |
| Chaston, TB; Lovejoy, DB; Richardson, DR; Watts, RN | 1 |
| Le, NT; Richardson, DR | 1 |
| Fu, D; Nurtjahja-Tjendraputra, E; Phang, JM; Richardson, DR | 1 |
1 review(s) available for deferoxamine and 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone
| Article | Year |
|---|---|
Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors.
Topics: Animals; Antineoplastic Agents; Humans; Iron; Iron Chelating Agents; Ribonucleotide Reductases; Thiosemicarbazones | 2009 |
14 other study(ies) available for deferoxamine and 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone
| Article | Year |
|---|---|
Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Line; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Ferric Compounds; Ferrous Compounds; Humans; Iron; Iron Chelating Agents; Ligands; Molecular Structure; Nitrobenzoates; Oxidation-Reduction; Protein Binding; Pyridines; Structure-Activity Relationship; Thiosemicarbazones; Transferrin | 2007 |
Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues.
Topics: Antineoplastic Agents; Ascorbic Acid; Benzoates; Cell Line; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Electrochemistry; Ferrous Compounds; Humans; Hydrazones; Hydroxylation; Iron; Iron Chelating Agents; Ligands; Molecular Structure; Oxidation-Reduction; Structure-Activity Relationship; Thiones; Transferrin | 2007 |
Structure-activity relationships of novel iron chelators for the treatment of iron overload disease: the methyl pyrazinylketone isonicotinoyl hydrazone series.
Topics: Antineoplastic Agents; Ascorbic Acid; Benzoates; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Humans; Hydrazones; Hydroxylation; Iron; Iron Chelating Agents; Iron Overload; Iron Radioisotopes; Isonicotinic Acids; Ketones; Ligands; Oxidation-Reduction; Pyrazines; Structure-Activity Relationship | 2008 |
2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Electrochemical Techniques; Humans; Iron; Iron Chelating Agents; Oxidation-Reduction; Pyridines; Stereoisomerism; Structure-Activity Relationship; Thiosemicarbazones; Transferrin | 2009 |
Halogenated 2'-benzoylpyridine thiosemicarbazone (XBpT) chelators with potent and selective anti-neoplastic activity: relationship to intracellular redox activity.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Line; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Electrochemistry; Fluoresceins; Fluorescent Dyes; Fluorometry; Humans; Hydrophobic and Hydrophilic Interactions; Iron Chelating Agents; Molecular Structure; Oxidation-Reduction; Pyridines; Reactive Oxygen Species; Structure-Activity Relationship; Thiosemicarbazones | 2011 |
Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumor efficacy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Deferoxamine; Humans; Iron; Iron Chelating Agents; Neoplasms; Quinolines; Thiosemicarbazones | 2012 |
Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Copper; Crystallography, X-Ray; Dimerization; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Injections, Intravenous; Ketones; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Oxidation-Reduction; Pyridines; Structure-Activity Relationship; Thiosemicarbazones; Transferrin; Transplantation, Heterologous | 2012 |
Alkyl substituted 2'-benzoylpyridine thiosemicarbazone chelators with potent and selective anti-neoplastic activity: novel ligands that limit methemoglobin formation.
Topics: Antineoplastic Agents; Ascorbic Acid; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Ferric Compounds; Ferrous Compounds; Humans; Iron Chelating Agents; Ligands; Methemoglobin; Molecular Structure; Oxidation-Reduction; Pyridines; Structure-Activity Relationship; Thiosemicarbazones; Transferrin | 2013 |
Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modifications.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Drug Stability; Humans; Hydrazines; Hydrazones; Hydrophobic and Hydrophilic Interactions; Iron Chelating Agents; Rats; Structure-Activity Relationship | 2016 |
The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: the effect of the ligands on molecular targets involved in proliferation.
Topics: Antineoplastic Agents; Cell Cycle; Cell Division; Chelation Therapy; Deferoxamine; Growth Inhibitors; Iron; Iron Chelating Agents; Isoniazid; Ligands; RNA, Neoplasm; Tumor Cells, Cultured | 1999 |
Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase.
Topics: Antineoplastic Agents; Cell Division; Deferoxamine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Hydroxyurea; Iron Chelating Agents; Isoniazid; Mutation; Protein Subunits; Ribonucleotide Reductases; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |
Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
Topics: Animals; Ascorbic Acid; Blotting, Northern; Blotting, Western; Cell Division; Chelating Agents; Deferoxamine; DNA; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Free Radicals; Glutathione; Humans; Iron; Iron Chelating Agents; Isoniazid; Models, Chemical; Oxidation-Reduction; Oxygen; Plasmids; Protein Binding; Pyridines; Rats; Thiosemicarbazones; Time Factors; Tumor Cells, Cultured | 2003 |
Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
Topics: Cell Cycle; Cells, Cultured; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Endopeptidases; Dactinomycin; Deferoxamine; DNA Damage; Gene Expression Regulation; Humans; Iron Chelating Agents; Isoniazid; Multienzyme Complexes; Proteasome Endopeptidase Complex; Protein Biosynthesis; Receptors, Transferrin; RNA, Messenger; Tumor Suppressor Protein p53 | 2003 |
Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression.
Topics: Anemia, Iron-Deficiency; Animals; Cell Cycle; Cell Line, Tumor; Deferoxamine; G1 Phase; Half-Life; Humans; Iron; Iron Chelating Agents; Isoniazid; Mice; Proteasome Endopeptidase Complex; S Phase; Siderophores; Ubiquitin | 2007 |